This infographic explores the current impact and future potential of bispecific antibodies in haematological malignancies. Covering their mechanism of action, approved bispecific antibodies, and their key advantages and limitations, it provides a comprehensive overview of this innovative treatment approach.
Bispecific Antibodies: A New Frontier in Haematologic Malignancies
23 Jul 2026
Download PDF
Hematology
Rate this content's potential impact on patient outcomes
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this content.






